logo
calendar27 Dekabr 2019
view30
Main language:Russian

Surgical treatment of renal cell carcinoma with the extension of the tumor into the right atrium

Field of Science:
pdf

file.pdf

PDF

ARTICLE ANNOTATION

quote
There is an increase in life expectancy after surgical treatment in patients with renal cell carcinoma (RCC), with the extension of tumor along the inferior vena cava (IVC) up to the right atrium. Depending on the extension of the tumor process, various surgical methods are offered for the treatment in this category of patients. We have presented the clinical experience of choosing an operational strategy depending on the degree of extension of a tumor thrombus.

AUTHORS

E.Boyko

Respublika ihtisoslashtirilgan onkologiya va radiologiya ilmiy-amaliy tibbiet markazi

Tags

# почечно-клеточный рак# опухолевый тромб# сердечнолёгочное шунтирование# renal cell carcinoma# tumor thrombus# cardiopulmonary bypass.# buyrak hujayrali saraton# shishli tromb# kardiopulmonar shuntlash

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

References

1. Allard C.B., Gelpi-Hammerschmidt F., Harshman L.C., Choueiri T.K., Faiena I., Modi P., et al. (2015) Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States. Urol Oncol 33(11): 496. e11–6. doi:10.1016/j. urolonc.2015.06.014;

2. Adler A., Gillon G., Lurie H., et al. (2017) Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immunoversus hormonotherapy. Preliminary report of immunological and clinical aspects. J Biol Response Mod.;6:610-624;

3. Amin M.B., Greene F.L., Edge S.B., et al. (2017) The eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin.;67:93-99;

4. Atzpodien J., Kirchner H., Illiger H.J., et al. (2017) IL-2 in combination with IFN-alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial. Br J Cancer.;85:1130-1136;

5. Tornberg S.V., Nisen H., Visapaa H. (2016) Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy. Scand J Urol.; 50(5): 380-386,

6. Zhu P., Du S., Chen S. (2018) The role of deep hypothermic circulatory arrest in surgery for renal or adrenal tumor with vena cava thrombus: a single-institution experience. // J Cardiothorac Surg. - 13(1). – 85-88

7. Master V.A., Ethun C.G., Kooby D.A., Staley C.A., Maithel S.K. (2018) The value of a cross-discipline team-based approach for resection of renal cell carcinoma with IVC tumor thrombus: A report of a large, contemporary, single-institution experience. // J Surg Oncol. - 118(8). - 1219-1226

8. Tillyashayhov M.N., Raximov N.M., Aloev B.B. (2018) Rezultati lecheniya bolnich rakom pochki oslojnennich trombozom v nijnyuyu poluyu venu i pravoe predserdie. //Klinicheskaya i eksperimentalnaya onkologiya. – Tashkent. №3(5). – S.25.

9. Davidov M.I., Matveev V.B., Volkova M.I. (2014) Faktori prognoza neposredstvennich rezultatov trombektomii u bolnich rakom pochki s opucholevim venoznim trombozom.// Onkourologiya. -№3.- S. 36-44